GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngene International Ltd (NSE:SYNGENE) » Definitions » Market Cap

Syngene International (NSE:SYNGENE) Market Cap : ₹276,471 Mil (As of May. 01, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Syngene International's share price for the quarter that ended in Mar. 2024 was ₹702.55. Syngene International's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 401 Mil. Therefore, Syngene International's market cap for the quarter that ended in Mar. 2024 was ₹281,562 Mil.

Syngene International's quarterly market cap declined from Sep. 2023 (₹321,349 Mil) to Dec. 2023 (₹281,099 Mil) but then increased from Dec. 2023 (₹281,099 Mil) to Mar. 2024 (₹281,562 Mil).

Syngene International's annual market cap declined from Mar. 2022 (₹237,888 Mil) to Mar. 2023 (₹237,557 Mil) but then increased from Mar. 2023 (₹237,557 Mil) to Mar. 2024 (₹281,562 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Syngene International's Enterprise Value for Today is ₹271,050 Mil.


Syngene International Market Cap Historical Data

The historical data trend for Syngene International's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Market Cap Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 95,228.36 217,380.00 237,888.42 237,557.44 281,561.67

Syngene International Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 237,557.44 305,723.93 321,348.79 281,099.07 281,561.67

Competitive Comparison of Syngene International's Market Cap

For the Biotechnology subindustry, Syngene International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syngene International's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Syngene International's Market Cap distribution charts can be found below:

* The bar in red indicates where Syngene International's Market Cap falls into.



Syngene International Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Syngene International's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹702.55*400.771
=₹281,562

Syngene International's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=₹702.55*400.771
=₹281,562

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International  (NSE:SYNGENE) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Syngene International Market Cap Related Terms

Thank you for viewing the detailed overview of Syngene International's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International (NSE:SYNGENE) Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International (NSE:SYNGENE) Headlines

No Headlines